Drug company founder put 'profits over patients' to push opioid: US prosecutor

  • 📰 ChannelNewsAsia
  • ⏱ Reading Time:
  • 35 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 17%
  • Publisher: 66%

Business News News

Business Business Latest News,Business Business Headlines

BOSTON: The founder of Insys Therapeutics Inc put profits over patients' safety by bribing doctors to prescribe an addictive fentanyl spray, ...

BOSTON: The founder of Insys Therapeutics Inc put profits over patients' safety by bribing doctors to prescribe an addictive fentanyl spray, fueling the U.S. opioid epidemic, a federal prosecutor said Thursday at the end of a landmark trial.

Yaeger said the Chandler, Arizona-based company paid doctors to act as speakers at sham events ostensibly meant to educate clinicians about Subsys, which contains fentanyl, a highly potent and addictive opioid. The U.S. Food and Drug Administration has approved Subsys for use only in treating severe pain in cancer patients. Yet Yaeger said the bribes were meant to cause doctors to prescribe the dangerous drug outside the usual course of medical practice.He said Kapoor also sought to defraud insurers into paying for Subsys and carried out the scheme with the help of his co-defendants, former Insys executives and managers Michael Gurry, Richard Simon, Sunrise Lee and Joseph Rowan.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 6. in BUSÄ°NESS

Business Business Latest News, Business Business Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

US to wrap case against drug company executives tied to opioid crisisProsecutors on Thursday will present their closing arguments in the trial of the wealthy founder of pharmaceutical company Insys Therapeutics Inc ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »